Mekinist (Trametinib) by Novartis Pharma

Last Updated On February 27, 2025 by Dr Divyensh

Mekinist (Trametinib) by Novartis Pharmaceuticals Corporation Indications and Usage Mekinist is a kinase inhibitor used for the treatment of various conditions: Melanoma with BRAF V600E or V600K mutations Unresectable or metastatic melanoma Metastatic non-small cell lung cancer (NSCLC) with BRAF V600E mutation Locally advanced or metastatic anaplastic thyroid cancer (ATC) with BRAF V600E mutation Unresectable … Read more